Skip to Main Content

Paper Details

Postoperative risk of IDH-mutant glioma-associated seizures and their potential management with IDH-mutant inhibitors.
J Clin Invest
7
2023
-neoplastic glial cells, Gliomas, IDH, IDH-mutant, IDH-mutant glioma, IDH-wild type (, IDH-wild type (IDHwt) gliomas, IDHmut, IDHwt, IDHwt), d-2-hydroxyglutarate, diffuse glioma, diffuse gliomas, glioma, gliomas, isocitrate, isocitrate dehydrogenase 1 or 2, patients, seizure, seizures, tumor
Author NameAffiliation
Dusten Unruh
Kathleen McCortney
Joanna J Phillips
Joanna J Phillips
Amy B Heimberger
Amy B HeimbergerLou and Jean Malnati Brain Tumor Institute of the Robert H. Lurie Comprehensive Cancer Center, Northwestern University
Jonathan E KurzMerck & Co. Inc.
Craig Horbinski
Craig HorbinskiLou and Jean Malnati Brain Tumor Institute of the Robert H. Lurie Comprehensive Cancer Center, Northwestern University
Craig Horbinski
  • 1 - 10

Datasets

Release 1.2